Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Werner Enterprises
WERN
$2.31B
| $2.11M | ﹤0.01% |
59,691
+40,818
| +216% | +$1.51M |
|
2777
CALL
LiveRamp
RAMP
$2.3B
| $2.1M | ﹤0.01% |
42,600
+37,100
| +675% | +$1.64M |
|
2778
Ameris Bancorp
ABCB
$6.01B
| $2.1M | ﹤0.01% |
45,999
+31,203
| +211% | +$1.55M |
|
|
CLDT
2779
Chatham Lodging
CLDT
$597M
| $2.1M | ﹤0.01% |
100,656
+42,897
| +74% | +$916K |
|
2780
Franklin Electric
FELE
$4.75B
| $2.1M | ﹤0.01% |
44,490
+29,795
| +203% | +$1.43M |
|
|
IMMU
2781
CALL
DELISTED
Immunomedics Inc
IMMU
| $2.1M | ﹤0.01% |
100,800
-74,100
| -42% | -$1.76M |
|
|
MIC
2782
PUT
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $2.1M | ﹤0.01% |
45,500
+400
| +0.9% | +$18.3K |
|
2783
Sabesp
SBS
$16.7B
| $2.1M | ﹤0.01% |
1,833,783
-3,130
| -0.2% | -$3.82K |
|
2784
Diageo
DEO
$52.9B
| $2.1M | ﹤0.01% |
14,788
+14,517
| +5,357% | +$2.08M |
|
|
LTXB
2785
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $2.09M | ﹤0.01% |
49,107
+32,642
| +198% | +$1.43M |
|
2786
Northwest Bancshares
NWBI
$2.32B
| $2.09M | ﹤0.01% |
120,725
+80,896
| +203% | +$1.46M |
|
2787
Commercial Metals
CMC
$8.03B
| $2.09M | ﹤0.01% |
101,784
+77,644
| +322% | +$1.67M |
|
|
NATI
2788
DELISTED
National Instruments Corp
NATI
| $2.09M | ﹤0.01% |
43,220
+29,041
| +205% | +$1.32M |
|
|
WBT
2789
DELISTED
Welbilt, Inc.
WBT
| $2.09M | ﹤0.01% |
100,024
+21,607
| +28% | +$476K |
|
2790
Northwest Natural Holdings
NWN
$2.14B
| $2.08M | ﹤0.01% |
31,171
+20,437
| +190% | +$1.33M |
|
2791
Asbury Automotive
ABG
$3.76B
| $2.08M | ﹤0.01% |
30,279
-6,899
| -19% | -$497K |
|
2792
Newmark Group
NMRK
$2.73B
| $2.08M | ﹤0.01% |
185,748
+180,209
| +3,253% | +$2.34M |
|
2793
Ultragenyx Pharmaceutical
RARE
$2.61B
| $2.08M | ﹤0.01% |
27,249
+16,246
| +148% | +$1.32M |
|
|
ACH
2794
Accendra Health
ACH
$86.1M
| $2.08M | ﹤0.01% |
125,880
+91,372
| +265% | +$1.55M |
|
2795
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
| $2.08M | ﹤0.01% |
+26,560
| New | +$2.08M |
|
2796
STAG Industrial
STAG
$7.18B
| $2.08M | ﹤0.01% |
75,472
+39,219
| +108% | +$1.09M |
|
2797
CALL
Agilent Technologies
A
$42.2B
| $2.07M | ﹤0.01% |
29,400
+700
| +2% | +$46.3K |
|
2798
PUT
PENN Entertainment
PENN
$2.56B
| $2.07M | ﹤0.01% |
63,000
-84,600
| -57% | -$2.82M |
|
2799
SPS Commerce
SPSC
$2.77B
| $2.07M | ﹤0.01% |
41,778
-11,516
| -22% | -$516K |
|
2800
CALL
Sibanye-Stillwater
SBSW
$7.47B
| $2.07M | ﹤0.01% |
832,000
| – | – |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.